Charlie Hospital Semarang Tbk. vs Semen Indonesia (Persero) Tbk. — how do they compare? Charlie Hospital Semarang Tbk. trades at Rp270 (market cap 742B, 29.45M 24h volume), while Semen Indonesia (Persero) Tbk. trades at Rp1,520 (market cap 10.16T, 13.77M 24h volume). The key difference: Semen Indonesia (Persero) Tbk. is far larger — about 13.7× Charlie Hospital Semarang Tbk.'s market cap, and Charlie Hospital Semarang Tbk. is more actively traded (29.45M versus 13.77M). Which is the better fit depends on your goals.
| RSCH | SMGR | |
|---|---|---|
Market Cap | 742B | 10.16T |
Volume | 29.45M | 13.77M |
Lot | 294.49K | 137.74K |
Turnover | 8.14B | 20.91B |
Average Price | 276.35 | 1,518.47 |
Value | 8.14B | 20.91B |
Indicative Equilibrium Price | 270 | 1,520 |
Indicative Equilibrium Volume | 103 | 6.87K |
Trailing returns across standard periods
Latest headlines on both assets
PT Charlie Hospital Semarang, Tbk (the "Company") was established based on Deed No. 35 dated 11 February 2019, which was made before Notary Nur Hadi, SH, MKn, notary in Kendal Regency and has been approved by the Minister of Law and Human Rights of the Republic of Indonesia based on Decree No. AHU-0008598.AH.01.01. Year 2019 February 11, 2019. The company started its commercial operations on September 23, 2019.
Read more on RSCH →PT Semen Indonesia (Persero) Tbk was established on March 25,1953 as NV Pabrik Semen Gresik. On April 17, 1961,NV Pabrik Semen Gresik was transformed into a state enterprise (Persero) by Government Regulation No. 132 year 1961, and subsequently became PT Semen Gresik (Persero). Semen Gresik is a cement producer which was formerly fully owned by the government. On July 1995 the company shareholders meeting agreed to acquired 100% share of two state owned cement producer companies, namely PT. Semen Tonasa and PT. Semen Padang.
Read more on SMGR →